Quarterlytics / Healthcare / Biotechnology / Immunic, Inc.

Immunic, Inc.

IMUX · NASDAQ Healthcare
Claim this profile
Ticker IMUX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Employees 91
Overview Coverage Annual Reports FAQ Peers Earnings Calls Financials News Management
Company Profile
Neuroprotection on Trial: Immunic's Campaign to Prove the Other Half of MS Matters
For three decades, multiple sclerosis treatment has been dominated by a single idea: stop the relapses, stop the disease. That approach built a $25 billion mark…
IMUX Jun 19, 2026